Company Info
Year Established2018
Ticker
NGNE
Exchange
NASDAQ
Contacts
Rachel McMinnFounder & CEO
Christine Mikail, J.D.
President & CFO
Stuart Cobb, Ph.D.
CSO
Company Description
Neurogene's focus is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases.
